| Literature DB >> 35965717 |
Mahdi Niknami1, Elham Emami2, Abdolhosein Mozaffari3, Hashem Sharifian4, Sanaz Safari1.
Abstract
Objectives: This study aimed to evaluate the correlation between the opacification degree of the paranasal sinuses on computed tomography (CT) with clinical symptoms, and anatomical variations of the nose and paranasal sinuses in patients with chronic rhinosinusitis (CRS). Materials andEntities:
Keywords: Anatomical Variation; Signs and Symptoms; Sinusitis; Tomography, X-Ray Computed
Year: 2021 PMID: 35965717 PMCID: PMC9355830 DOI: 10.18502/fid.v18i33.7337
Source DB: PubMed Journal: Front Dent ISSN: 2676-296X
Percentage of patients with a specific symptom and the mean visual analog scale score for each symptom
| Symptoms | Mild | Moderate | Severe | Patients | Patients | Mean |
|---|---|---|---|---|---|---|
| Purulent (discolored) | 22 | 28 | 48 | 98 | 2 | 6.14 |
| Nasal obstruction/blockage | 12 | 28 | 57 | 97 | 3 | 6.66 |
| Facial pain/pressure/fullness | 33 | 24 | 15 | 72 | 28 | 3.21 |
| Facial congestion/fullness | 22 | 30 | 13 | 65 | 35 | 2.96 |
| Hyposmia/anosmia | 25 | 20 | 29 | 74 | 26 | 4.08 |
| Headache | 18 | 25 | 35 | 78 | 22 | 4.81 |
| Ear pain/pressure/fullness | 17 | 15 | 9 | 41 | 59 | 1.89 |
| Halitosis | 21 | 23 | 20 | 54 | 46 | 2.83 |
| Dental pain | 11 | 9 | 5 | 25 | 75 | 1.07 |
| Cough | 21 | 10 | 13 | 44 | 56 | 2.05 |
| Fatigue | 28 | 29 | 7 | 65 | 35 | 2.65 |
| Fever | 16 | 2 | 1 | 19 | 81 | 0.52 |
| Total | 50 | 44 | 6 | 100 | 0 | 3.23 |
Incidence (%) of anatomical variations in the nose and paranasal sinuses
| Normal anatomical variation | Unilateral | Bilateral | Total Positive | Total Negative | |
|---|---|---|---|---|---|
| Right | Left | ||||
| Septal deviation | 55 | 51 | 11 | 95 | 5 |
| Spur formation | 32 | 24 | 3 | 53 | 47 |
| Concha bullosa | 22 | 17 | 12 | 27 | 73 |
| Paradoxical middle concha | 6 | 9 | 0 | 15 | 85 |
| Agger nasi cell | 42 | 40 | 40 | 44 | 56 |
| Haller cell | 10 | 6 | 3 | 13 | 87 |
| Onodi cell | 27 | 13 | 11 | 29 | 71 |
Percentage of patients with a specific sinus opacification and the Lund Mackay mean score for each sinus
| Sinus | Opacification degree (%) | Mean score | ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| Right maxillary | 7 | 68 | 10 | 8 | 7 | 1.4 |
| Left maxillary | 7 | 64 | 15 | 11 | 3 | 1.39 |
| Bilateral maxillary | 4 | 55 | 6 | 5 | 2 | 2.79 |
| Right anterior ethmoid | 18 | 50 | 23 | 6 | 3 | 1.26 |
| Left anterior ethmoid | 20 | 47 | 22 | 9 | 2 | 1.26 |
| Bilateral anterior | 13 | 42 | 19 | 5 | 2 | 2.52 |
| Right posterior ethmoid | 42 | 31 | 22 | 4 | 1 | 0.91 |
| Left posterior ethmoid | 43 | 30 | 21 | 5 | 1 | 0.91 |
| Bilateral posterior | 38 | 28 | 19 | 4 | 1 | 1.82 |
| Right sphenoid | 63 | 27 | 4 | 5 | 1 | 0.54 |
| Left sphenoid | 59 | 31 | 4 | 5 | 1 | 0.58 |
| Bilateral sphenoid | 55 | 22 | 2 | 3 | 0 | 1.12 |
| Right frontal | 62 | 31 | 5 | 2 | 0 | 0.47 |
| Left frontal | 63 | 26 | 9 | 2 | 0 | 0.50 |
| Bilateral frontal | 58 | 23 | 4 | 2 | 0 | 0.97 |
Percentage and association of left and right anatomical variations and sinus involvement (Spearman’s correlation coefficient)
| Normal | Side | Sinus | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
|
| ||
| Septal deviation |
| 48 | 0.894 | 38 | 0.935 | 28 | 0.962 | 26 | 0.020* | 23 | 0.114 |
|
| 50 | 0.801 | 46 | 0.722 | 32 | 0.941 | 21 | 0.736 | 22 | 0.686 | |
| Spur formation |
| 23 | 0.929 | 19 | 0.969 | 15 | 0.634 | 14 | 0.056 | 8 | 0.654 |
|
| 30 | 0.283 | 28 | 0.497 | 21 | 0.545 | 11 | 0.822 | 13 | 0.779 | |
| Concha bullosa |
| 16 | 0.476 | 13 | 0.845 | 9 | 0.907 | 7 | 0.733 | 5 | 0.760 |
|
| 22 | 0.469 | 17 | 0.763 | 12 | 0.818 | 10 | 0.302 | 10 | 0.233 | |
| Paradoxical |
| 9 | 0.006* | 9 | 0.006* | 8 | 0.054 | 5 | 0.253 | 4 | 0.871 |
|
| 6 | 0.000* | 5 | 0.064 | 5 | 0.030* | 4 | 0.034* | 5 | 0.003* | |
| Agger nasi cell |
| 38 | 0.340 | 32 | 0.359 | 24 | 0.856 | 19 | 0.640 | 16 | 0.919 |
|
| 37 | 0.026* | 32 | 0.220 | 22 | 0.318 | 15 | 0.677 | 15 | 0.598 | |
| Haller cell |
| 6 | 0.095 | 6 | 0.076 | 4 | 0.688 | 5 | 0.016* | 3 | 0.497 |
|
| 9 | 0.037* | 8 | 0.172 | 7 | 0.175 | 5 | 0.221 | 6 | 0.151 | |
| Onodi cell |
| 12 | 0.947 | 10 | 0.665 | 8 | 0.691 | 7 | 0.197 | 5 | 0.839 |
|
| 26 | 0.310 | 21 | 0.837 | 16 | 0.830 | 11 | 0.624 | 12 | 0.462 | |
Percentage and correlation of symptoms with involvement of the paranasal sinuses (Spearman’s correlation coefficient)
| Symptoms | Sinus | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
| |
| Purulent (discolored) anterior | 95 | 0.042* | 86 | 0.094 | 62 | 0.608 | 44 | 0.846 | 41 | 0.144 |
| Nasal obstruction/blockage | 93 | 0.352 | 84 | 0.230 | 59 | 0.010* | 42 | 0.606 | 40 | 0.162 |
| Facial pain/pressure/fullness | 70 | 0.233 | 66 | 0.055 | 48 | 0.212 | 34 | 0.409 | 34 | 0.344 |
| Facial congestion/fullness | 64 | 0.95 | 58 | 0.555 | 43 | 0.429 | 30 | 0.927 | 31 | 0.271 |
| Hyposmia/anosmia | 73 | 0.231 | 69 | 0.002 | 51 | 0.010* | 36 | 0.051 | 35 | 0.010* |
| Headache | 76 | 0.519 | 69 | 0.684 | 49 | 0.759 | 35 | 0.409 | 31 | 0.483 |
| Ear pain/pressure/fullness | 40 | 0.505 | 32 | 0.093 | 24 | 0.797 | 19 | 0.880 | 18 | 0.791 |
| Halitosis | 51 | 0.531 | 47 | 0.402 | 34 | 0.961 | 31 | 0.046* | 23 | 0.742 |
| Dental pain | 25 | 0.240 | 21 | 0.738 | 14 | 0.534 | 10 | 0.532 | 8 | 0.289 |
| Cough | 44 | 0.088 | 40 | 0.472 | 31 | 0.148 | 24 | 0.122 | 25 | 0.010* |
| Fatigue | 62 | 0.986 | 58 | 0.847 | 42 | 0.257 | 29 | 0.862 | 30 | 0.026* |
| Fever | 19 | 0.331 | 18 | 0.300 | 15 | 0.116 | 10 | 0.549 | 10 | 0.315 |
Prevalence of sinonasal anatomical variations (%) in previous studies
| Study | Year | Septal | Spur | Concha | Paradoxical | Agger nasi cell | Haller cell | Onodi cell |
|---|---|---|---|---|---|---|---|---|
| Present study | 2019 | 95 | 53 | 27 | 15 | 44 | 13 | 29 |
| Bijani et al [ | 2018 | 73.8 | - | 29.1 | 11.7 | 5.8 | 5.2 | - |
| Sarkar et al [ | 2016 | 74.8 | - | 32.9 | 6.7 | 3.5 | 18 | 2.6 |
| Shpilberg et al [ | 2015 | 98.4 | 32.3 | 26 | 15.6 | 83.3 | 39.1 | 12 |
| Khajavi et al [ | 2015 | 49 | 12 | 26 | 5 | - | - | - |
| Kaygusuz et al [ | 2014 | 72.3 | - | 41.5 | 13.8 | 64.6 | 13.8 | 9.2 |
| Shrikrishna et al [ | 2013 | 30 | - | 38 | 5 | 6 | 11 | - |
| Fadda et al [ | 2012 | 58.5 | - | 49.3 | 6.4 | 24.3 | 22.8 | 8.5 |
| Nitinavakarn et al [ | 2005 | - | - | 50 | - | 92 | 23.9 | 25 |
| Arslan et al [ | 1999 | - | - | 30 | 3 | - | 12 | 10 |
| Bolger et al [ | 1991 | 96 | - | 53.6 | 27.1 | 98.5 | 45.9 | 11 |
Prevalence of sinus opacities (%) in some studies
| Study | Year | Sinus involvement | ||||
|
|
|
|
|
| ||
| Present study | 2019 | 96 | 87 | 62 | 45 | 42 |
| Sarkar et al [ | 2016 | 82.5 | 43.8 | 43.2 | 27.7 | 28.7 |
| Amodu et al [ | 2014 | 81.7 | 68.3 | 68.3 | 20 | 40 |
| Ryan et al [ | 2011 | 72.5 | 58.8 | 54.9 | 43.1 | 58.8 |
| Lloyd et al [ | 1991 | 83 | 63 | 57 | 49 | 60 |
| Bolger et al [ | 1991 | 77.7 | 84.3 | 38.6 | 25.4 | 36.6 |